2nd Apr 2007 12:49
GlaxoSmithKline PLC02 April 2007 Total Voting Rights and Capital as at 31 March 2007 In conformity with the Disclosure and Transparency Rules 5.6.1R, GlaxoSmithKlineplc ("the Company") hereby notifies the market of the following: The Company's issued share capital as at 31 March 2007 consists of 6,010,402,644Ordinary shares of 25p each with voting rights, of which 281,382,678 Ordinaryshares are held in Treasury. Therefore, the total number of voting rights in the Company is 5,729,019,966.This figure may be used by shareholders as the denominator for the calculationsby which they will determine if they are required to notify their interest in,or a change to their interest in, the Company under the Financial ServicesAuthority's Disclosure and Transparency Rules. S M Bicknell Company Secretary 2 April 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline